172 related articles for article (PubMed ID: 30911077)
1. HPV-negative tumors of the uterine cervix.
Nicolás I; Marimon L; Barnadas E; Saco A; Rodríguez-Carunchio L; Fusté P; Martí C; Rodriguez-Trujillo A; Torne A; Del Pino M; Ordi J
Mod Pathol; 2019 Jul; 32(8):1189-1196. PubMed ID: 30911077
[TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix.
Nicolás I; Saco A; Barnadas E; Marimon L; Rakislova N; Fusté P; Rovirosa A; Gaba L; Buñesch L; Gil-Ibañez B; Pahisa J; Díaz-Feijoo B; Torne A; Ordi J; Del Pino M
Mod Pathol; 2020 Jan; 33(1):128-137. PubMed ID: 31492932
[TBL] [Abstract][Full Text] [Related]
3. HPV-negative carcinoma of the uterine cervix: a distinct type of cervical cancer with poor prognosis.
Rodríguez-Carunchio L; Soveral I; Steenbergen RD; Torné A; Martinez S; Fusté P; Pahisa J; Marimon L; Ordi J; del Pino M
BJOG; 2015 Jan; 122(1):119-27. PubMed ID: 25229645
[TBL] [Abstract][Full Text] [Related]
4. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
5. The overexpression of p16 is not a surrogate marker for high-risk human papilloma virus genotypes and predicts clinical outcomes for vulvar cancer.
Sznurkowski JJ; Żawrocki A; Biernat W
BMC Cancer; 2016 Jul; 16():465. PubMed ID: 27411473
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus (HPV) DNA in primary cervical cancer and in cancer free pelvic lymph nodes--correlation with clinico-pathological parameters and prognostic significance.
Pilch H; Günzel S; Schäffer U; Tanner B; Brockerhoff P; Maeurer M; Höckel M; Hommel G; Knapstein PG
Zentralbl Gynakol; 2001 Feb; 123(2):91-101. PubMed ID: 11265139
[TBL] [Abstract][Full Text] [Related]
7. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
8. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
[TBL] [Abstract][Full Text] [Related]
9. P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer-A Large Cohort of Two Tertiary Referral Centers.
da Mata S; Ferreira J; Nicolás I; Esteves S; Esteves G; Lérias S; Silva F; Saco A; Cochicho D; Cunha M; Del Pino M; Ordi J; Félix A
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669021
[TBL] [Abstract][Full Text] [Related]
10. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
[TBL] [Abstract][Full Text] [Related]
11. Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study.
Prigenzi KCK; Heinke T; Salim RC; Focchi GRA
Acta Cytol; 2018; 62(2):104-114. PubMed ID: 29566392
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment.
Lau YM; Cheung TH; Yeo W; Mo F; Yu MY; Lee KM; Ho WC; Yeung AC; Law PT; Chan PK
PLoS One; 2015; 10(4):e0122557. PubMed ID: 25855986
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of CK7, HPV-L1, and koilocytosis for patients with cervical low-grade squamous intraepithelial lesions: a retrospective analysis.
Cao L; Sun PL; Yao M; Chen S; Gao H
Hum Pathol; 2017 Jul; 65():194-200. PubMed ID: 28554573
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
[TBL] [Abstract][Full Text] [Related]
17. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
Clarke MA; Cheung LC; Castle PE; Schiffman M; Tokugawa D; Poitras N; Lorey T; Kinney W; Wentzensen N
JAMA Oncol; 2019 Feb; 5(2):181-186. PubMed ID: 30325982
[TBL] [Abstract][Full Text] [Related]
18. Detection of human papillomavirus in small cell carcinomas of the anus and rectum.
Cimino-Mathews A; Sharma R; Illei PB
Am J Surg Pathol; 2012 Jul; 36(7):1087-92. PubMed ID: 22531171
[TBL] [Abstract][Full Text] [Related]
19. HPV-DNA, vascular space invasion, and their impact on the clinical outcome in early-stage cervical carcinomas.
Graflund M; Sorbe B; Sigurdardóttir S; Karlsson M
Int J Gynecol Cancer; 2004; 14(5):896-902. PubMed ID: 15361201
[TBL] [Abstract][Full Text] [Related]
20. Absence of human papillomavirus infection and activation of PI3K-AKT pathway in cervical clear cell carcinoma.
Ueno S; Sudo T; Oka N; Wakahashi S; Yamaguchi S; Fujiwara K; Mikami Y; Nishimura R
Int J Gynecol Cancer; 2013 Jul; 23(6):1084-91. PubMed ID: 23792604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
